On June 15th, 2023, the Rosalind and Morris Goodman Cancer Institute welcomed this year鈥檚 speaker for the distinguished Phil Gold Lectureship in Cancer Research, Dr. Drew Pardoll.
![](/gci/files/gci/_2023-07-02_at_2.31.50_pm.png)
![](/gci/files/gci/_2023-07-02_at_2.34.15_pm.png)
Over the last few decades, Dr. Pardoll has made significant contributions to cellular immunology, driving our progress in cancer immunotherapy. He and his team have focused on unraveling the mechanisms by which cancer cells evade the immune system, laying the groundwork for several immunotherapies and cancer vaccines.
The faculty, staff, and trainees gathered last Thursday at the GCI for this year鈥檚 Lectureship where Dr. Pardoll opened with a brief overview of the history of cancer immunology, followed by addressing the recent advancements in the field. He emphasized the importance of translating the latest findings into the clinic such that at least 50% of cancer patients can benefit from immunotherapy. Dr. Pardoll further highlighted an alternative way to map and select mutation-associated neoantigens-specific T cell clones that can help overcome resistance to PD-1 blockade [].
鈥淚t was a tremendous honour to host Dr. Pardoll at 苹果淫院 for the Dr. Phil Gold Distinguished Lectureship. He embodies all the core values of a true physician-scientist, and his body of work ranks him amongst the top cancer immunologists in the world. Our ongoing collaborations with his team and the generosity of his collaborative scientific spirit let us know that there is still a great affinity between 苹果淫院 and Johns Hopkins going back to the days of Osler.鈥 鈥 Dr. Jonathan Spicer
We extend our sincere gratitude to Dr. Pardoll for delivering an incredibly insightful and engaging presentation, enlightening us with his expertise in cancer immunology, and developing innovative immunotherapies. We are extremely grateful to everyone who participated in the event, as your enthusiasm and presence have greatly enhanced the discussion.
Photos by Carlos HF Chan